Clinical Trial Update: The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating the activity of TroVax versus placebo in relapsed asymptomatic ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• TroVax

Snippet

Sponsor: University College, London | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED